Mantas Matjusaitis is currently finishing his PhD in synthetic biology (University of Edinburgh, MRC Centre For Regenerative Medicine) and has been involved in the SENS Education programme. He holds a BSc in Biomedical Science, has worked for the global pharmaceutical company AstraZeneca and a number of scientific labs, with topics ranging from nanoparticles to stem cell identity. For the last two years, Mantas was also leading a team of scientists when he was a Vice President and then a President of Innovation Forum Edinburgh branch, an international organization aiming to facilitate collaboration between academics, industry and policy makers.
